Regulation of acute kidney injury to Candida albicans by b-catenin/TCF pathway
b-catenin/TCF通路调控白色念珠菌急性肾损伤
基本信息
- 批准号:10495218
- 负责人:
- 金额:$ 19.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-24 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcute Renal Failure with Renal Papillary NecrosisAnti-Inflammatory AgentsAntigen-Presenting CellsBone Marrow TransplantationCandida albicansCell Differentiation processCellsClinicalDataDendritic CellsDisseminated candidiasisEpithelial CellsFelis catusGenetic TranscriptionImmuneImmune responseImmune systemImmunityImmunocompromised HostImmunosuppressive AgentsIn VitroInfectionInflammasomeInflammatory ResponseInjuryInjury to KidneyInnate Immune ResponseKidneyKidney FailureKnockout MiceLinkMAP Kinase GeneMalignant NeoplasmsMediatingMediator of activation proteinMetabolicMetabolic PathwayModelingMolecularMorbidity - disease rateOrganPathogenicityPathway interactionsPatientsPharmaceutical PreparationsPharmacologyPlayPredispositionPreventionReagentRegulationRegulatory PathwayRenal functionRoleShapesSignal PathwaySignal TransductionTCF7L2 geneTestingTherapeuticTimeTransplant RecipientsTubular formationVaccinesadaptive immune responseantimicrobial peptidebeta cateninconditional knockoutimmunogenicin vivokidney infectionmacrophagemortalitynew therapeutic targetpathogenic fungusprogramsrenal damageresponsetranscription factor
项目摘要
Summary: Candida albicans infection is the third most common infection in hospitalized patients, with a
mortality rate ranging between 14.5%–49%. Disseminated candidiasis causes kidney failure resulting in
severe morbidity of the immunocompromised host such as those with acquired immune deficiency syndrome
or cancer, organ or bone marrow transplant patients, or patients taking immunosuppressant drugs an extended
period of time. Prevention and treatment of disseminated candidiasis are an important clinical problem, and
currently, there are no approved vaccines against any fungal pathogens. However, the cellular and molecular
mechanisms underlying renal failure caused by pathogenic Candida albicans infection remain largely unknown.
The immune system plays an important role in protecting against disseminated candidiasis. Immune activating
pathways in renal antigen-presenting cells (APCs) play a critical role in inducing robust immune responses in
the kidney against C. albicans. In contrast, the anti-inflammatory pathways in APCs suppress immune
responses in the kidney against C. albicans and increasing susceptibility to kidney damage and failure. Thus,
identifying the signaling pathways that program APCs towards an immunogenic state versus a regulatory state
will help identify new targets for therapeutic manipulation of immune cells that augments kidney immunity
against Candida albicans and protects against infection-associated-kidney damage and failure. We have
identified a new and previously unsuspected role for β-catenin and TCF4 as a key molecular anti-inflammatory
pathway in APCs that is critical for suppressing immune responses against disseminated candidiasis, causing
increased susceptibility to kidney damage and failure. This application aims to delineate the molecular
mechanisms by which β-catenin and TCF4 metabolically program renal APCs against disseminated
candidiasis and its impact on kidney function.
总结:白色念珠菌感染是住院患者第三常见的感染,其中
死亡率在14.5%-49%之间。播散性念珠菌病导致肾衰竭,
免疫功能低下宿主的严重发病率,如患有获得性免疫缺陷综合征的宿主
或癌症、器官或骨髓移植患者,或长期服用免疫抑制药物的患者,
段时间播散性念珠菌病的预防和治疗是一个重要的临床问题,
目前还没有针对任何真菌病原体的批准疫苗。然而,细胞和分子
致病性白色念珠菌感染引起的肾衰竭的潜在机制在很大程度上仍然未知。
免疫系统在预防播散性念珠菌病方面起着重要作用。免疫活化
肾抗原呈递细胞(APC)中的免疫通路在诱导免疫应答中起着关键作用。
肾脏对C.白色念珠菌相反,APC中的抗炎通路抑制免疫反应。
肾脏对C.白色念珠菌和增加对肾损伤和衰竭的易感性。因此,在本发明中,
鉴定将APC编程为免疫原性状态相对于调节状态的信号通路
将有助于确定新的目标,用于增强肾脏免疫力的免疫细胞的治疗操作
抗白色念珠菌,并防止感染相关的肾损伤和衰竭。我们有
确定了β-连环蛋白和TCF 4作为关键的抗炎分子的一种新的和以前未被怀疑的作用,
APCs中的途径,对于抑制针对播散性念珠菌病的免疫应答至关重要,
增加对肾损伤和衰竭的易感性。本申请旨在描述分子生物学中的
β-连环蛋白和TCF 4代谢编程肾APC对抗播散性
念珠菌病及其对肾功能的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Santhakumar Manicassamy其他文献
Santhakumar Manicassamy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Santhakumar Manicassamy', 18)}}的其他基金
Regulation of acute kidney injury to Candida albicans by b-catenin/TCF pathway
b-catenin/TCF通路调控白色念珠菌急性肾损伤
- 批准号:
10373167 - 财政年份:2021
- 资助金额:
$ 19.25万 - 项目类别:
Regulation of colitis associated with acute kidney injury by the Wnt pathway
Wnt 通路调节与急性肾损伤相关的结肠炎
- 批准号:
10320015 - 财政年份:2020
- 资助金额:
$ 19.25万 - 项目类别:
Regulation of colitis associated with acute kidney injury by the Wnt pathway
Wnt 通路调节与急性肾损伤相关的结肠炎
- 批准号:
10084294 - 财政年份:2020
- 资助金额:
$ 19.25万 - 项目类别:
Regulation of colitis associated with acute kidney injury by the Wnt pathway
Wnt 通路调节与急性肾损伤相关的结肠炎
- 批准号:
10542352 - 财政年份:2020
- 资助金额:
$ 19.25万 - 项目类别:
Programming dendritic cells to induce tolerogenic response and suppress brain inf
对树突状细胞进行编程以诱导耐受反应并抑制大脑信息
- 批准号:
8716336 - 财政年份:2013
- 资助金额:
$ 19.25万 - 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
- 批准号:
8547805 - 财政年份:2012
- 资助金额:
$ 19.25万 - 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
- 批准号:
8421463 - 财政年份:2012
- 资助金额:
$ 19.25万 - 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
- 批准号:
8688238 - 财政年份:2012
- 资助金额:
$ 19.25万 - 项目类别:
Regulation of Oral Tolerance and Intestinal Inflammation by Beta-catenin/TCF Path
Beta-catenin/TCF 路径对口服耐受性和肠道炎症的调节
- 批准号:
9079468 - 财政年份:2012
- 资助金额:
$ 19.25万 - 项目类别:














{{item.name}}会员




